Vogenx, Inc. (VOGX)
18.72
+0.49
(+2.69%)
USD |
NASDAQ |
Nov 06, 10:20
Vogenx EPS Diluted (Quarterly) : -0.0259 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0259 |
| March 31, 2026 | -0.032 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.0198 |
| March 31, 2025 | -0.024 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IGC Pharma, Inc. | -0.0293 |
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Arvinas, Inc. | -0.8242 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.3844M |
| Total Expenses (Quarterly) | 0.3844M |
| Enterprise Value | 271.48M |
| Earnings Yield | -0.54% |
| Normalized Earnings Yield | -0.5395 |